Chronic administration of nicotine enhances NMDA-activated currents in the prefrontal cortex and core part of the nucleus accumbens of rats

Synapse

Volumn 68, Issue 6, 2014, Pages 248-256

  Ávila Ruiz, Tania ^a   Carranza, Vladimir ^a   Gustavo, López López ^a   Limón, Daniel I ^a   Martínez, Isabel ^a   Flores, Gonzalo ^a   Flores Hernández, Jorge ^a  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

Author keywords

Locomotive activity; Nicotine; NMDA; Nucleus accumbens; Prefrontal cortex

Indexed keywords

MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NICOTINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; GANGLION STIMULATING AGENT; MAGNESIUM DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYLASPARTIC ACID; NR2B NMDA RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN ELECTROPHYSIOLOGY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTRON IONIZATION MASS SPECTROMETY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; LONG TERM EXPOSURE; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RADIOIMMUNOASSAY; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CELL CULTURE; DRUG EFFECTS; IN VITRO STUDY; MEMBRANE POTENTIAL; METABOLISM; MOTOR ACTIVITY; NERVE CELL; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; CELLS, CULTURED; GANGLIONIC STIMULANTS; IN VITRO TECHNIQUES; MAGNESIUM COMPOUNDS; MALE; MEMBRANE POTENTIALS; MOTOR ACTIVITY; N-METHYLASPARTATE; NEURONS; NEUROTRANSMITTER AGENTS; NICOTINE; NUCLEUS ACCUMBENS; PATCH-CLAMP TECHNIQUES; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84897487179     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21726     Document Type: Article

References (66)

1. Abreu-Villaca Y, Seidler FJ, Tate CA, Slotkin TA. 2003. Nicotine is a neurotoxin in the adolescent brain: Critical periods, patterns of exposure, regional selectivity, and dose thresholds for macromolecular alterations. Brain Res 979:114-128.
2. Andre VM, Flores-Hernandez J, Cepeda C, Starling AJ, Nguyen S, Lobo MK, Vinters HV, Levine MS, Mathern GW. 2004. NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. Cereb Cortex 14:634-646.
3. Aramakis VB, Metherate R. 1998. Nicotine selectively enhances NMDA receptor-mediated synaptic transmission during postnatal development in sensory neocortex. J Neurosci 18:8485-8495.
4. Baldwin AE, Sadeghian K, Holahan MR, Kelley AE. 2002. Appetitive instrumental learning is impaired by inhibition of cAMP-dependent protein kinase within the nucleus accumbens. Neurobiol Learn Mem 77:44-62.
5. Bargas J, Howe A, Eberwine J, Cao Y, Surmeier DJ. 1994. Cellular and molecular characterization of Ca2+ currents in acutely isolated, adult rat neostriatal neurons. J Neurosci 14:6667-6686.
6. Basar K, Sesia T, Groenewegen H, Steinbusch HW, Visser-Vandewalle V, Temel Y. 2010. Nucleus accumbens and impulsivity. Prog Neurobiol 92:533-557.
7. Benwell ME, Balfour DJ, Birrell CE. 1995. Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine. Br J Pharmacol 114:454-460.
8. Bergstrom HC, Smith RF, Mollinedo NS, McDonald CG. 2010. Chronic nicotine exposure produces lateralized, age-dependent dendritic remodeling in the rodent basolateral amygdala. Synapse 64:754-764.
9. Bossert JM, Poles GC, Wihbey KA, Koya E, Shaham Y. 2007. Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues. J Neurosci 27:12655-12663.
10. Brown RW, Kolb B. 2001. Nicotine sensitization increases dendritic length and spine density in the nucleus accumbens and cingulate cortex. Brain Res 899:94-100.
11. Campello L, Esteve-Rudd J, Cuenca N, Martín-Nieto J. 2013. The ubiquitin-proteasome system in retinal health and disease. Mol Neurobiol 2:790-810.
12. Chaudhri N, Sahuque LL, Schairer WW, Janak PH. 2010. Separable roles of the nucleus accumbens core and shell in context- and cue-induced alcohol-seeking. Neuropsychopharmacology 35:783-791.
13. Chen T, Zhang D, Dragomir A, Kobayashi K, Akay Y, Akay M. 2011. Investigating the influence of PFC transaction and nicotine on dynamics of AMPA and NMDA receptors of VTA dopaminergic neurons. J Neuroeng Rehabil 8:58.
14. Dajas-Bailador F, Wonnacott S. 2004. Nicotinic acetylcholine receptors and the regulation of neuronal signaling. Trends Pharmacol Sci 25:317-324.
15. Dandekar MP, Nakhate KT, Kokare DM, Subhedar NK. 2010. Effect of nicotine on feeding and body weight in rats: Involvement of cocaine- and amphetamine-regulated transcript peptide. Behav Brain Res 219:31-38.
16. Dani JA, De Biasi M. 2001. Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav 70:439-446.
17. Dani JA, Ji D, Zhou FM. 2001. Synaptic plasticity and nicotine addiction. Neuron 31:349-352.
18. Del Arco A, Segovia G, Mora F. 2008. Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity. Psychopharmacology (Berl) 201:325-338.
19. Elliott BM, Faraday MM, Phillips JM, Grunberg NE. 2004. Effects of nicotine on elevated plus maze and locomotor activity in male and female adolescent and adult rats. Pharmacol Biochem Behav 77:21-28.
20. Fallon S, Shearman E, Sershen H, Lajtha A. 2007. The effects of glutamate and GABA receptor antagonists on nicotine-induced neurotransmitter changes in cognitive areas. Neurochem Res 32:535-553.
21. Faraday MM, Elliott BM, Grunberg NE. 2001. Adult vs adolescent rats differ in biobehavioral responses to chronic nicotine administration. Pharmacol Biochem Behav 70:475-489.
22. Flores-Hernandez J, Hernandez S, Snyder GL, Yan Z, Fienberg AA, Moss SJ, Greengard P, Surmeier DJ. 2000. D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade. J Neurophysiol 83:2996-3004.
23. Flores-Hernandez J, Salgado H, De La Rosa V, Avila-Ruiz T, Torres-Ramirez O, Lopez-Lopez G, Atzori M. 2009. Cholinergic direct inhibition of N-methyl-D aspartate receptor-mediated currents in the rat neocortex. Synapse 63:257-264.
24. French SJ, Totterdell S. 2003. Individual nucleus accumbens-projection neurons receive both basolateral amygdala and ventral subicular afferents in rats. Neuroscience 119:19-31.
25. Fu Y, Matta SG, Gao W, Brower VG, Sharp BM. 2000. Systemic nicotine stimulates dopamine release in nucleus accumbens: Re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area. J Pharmacol Exp Ther 294:458-465.
26. Garcia-Keller C, Martinez SA, Esparza MA, Bollati F, Kalivas PW, Cancela LM. 2013. Cross-sensitization between cocaine and acute restraint stress is associated with sensitized dopamine but not glutamate release in the nucleus accumbens. Eur J Neurosci 37:982-995.
27. Gonzalez CL, Gharbawie OA, Whishaw IQ, Kolb B. 2005. Nicotine stimulates dendritic arborization in motor cortex and improves concurrent motor skill but impairs subsequent motor learning. Synapse 55:183-191.
28. Greengard P, Allen PB, Nairn AC. 1999. Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade. Neuron 23:435-447.
29. Grilli M, Pittaluga A, Merlo-Pich E, Marchi M. 2009. NMDA-mediated modulation of dopamine release is modified in rat prefrontal cortex and nucleus accumbens after chronic nicotine treatment. J Neurochem 108:408-416.
30. Groenewegen HJ, Galis-de Graaf Y, Smeets WJ. 1999. Integration and segregation of limbic cortico-striatal loops at the thalamic level: An experimental tracing study in rats. J Chem Neuroanat 16:167-185.
31. Iñiguez SD, Warren BL, Parise EM, Alcantara LF, Schuh B, Maffeo ML, Manojlovic Z, Bolanos-Guzman CA. 2009. Nicotine exposure during adolescence induces a depression-like state in adulthood. Neuropsychopharmacology 34:1609-1624.
32. Ito R, Robbins TW, Pennartz CM, Everitt BJ. 2008. Functional interaction between the hippocampus and nucleus accumbens shell is necessary for the acquisition of appetitive spatial context conditioning. J Neurosci 28:6950-6959.
33. Jain R, Mukherjee K, Balhara YP. 2008. The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: A preclinical review. Yonsei Med J 49:175-188.
34. Kayir H, Goktalay G, Yildirim M, Uzbay T. 2009. Clozapine inhibits development and expression of nicotine-Induced locomotor sensitization in rats. Synapse 63:15-21.
35. Kenny PJ, Chartoff E, Roberto M, Carlezon WA, Jr, Markou A. 2009. NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: Role of the ventral tegmental area and central nucleus of the amygdala. Neuropsychopharmacology 34:266-281.
36. Lança AJ, De Cabo C, Arifuzzaman AL, Vaccarino FJ. 1998. Cholecystokinergic innervation of nucleus accumbens subregions. Peptides 19:859-868.
37. Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni AL, Pistis M. 2011. Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology 36:589-602.
38. Levy RB, Reyes AD, Aoki C. 2006. Nicotinic and muscarinic reduction of unitary excitatory postsynaptic potentials in sensory cortex; dual intracellular recording in vitro. J Neurophysiol 95:2155-2166.
39. Mansvelder HD, McGehee DS. 2000. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27:349-357.
40. Mansvelder HD, Mertz M, Role LW. 2009. Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol 20:432-440.
41. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stoleman IP, Tyndale RF, Wehner JM, Zirger JM. 2007. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190:269-319.
42. Mugnaini M, Garzotti M, Sartori I, Pilla M, Repeto P, Heidbreder CA, Tessari M. 2006. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine. Neuroscience 137:565-572.
43. Neff RA, Humphrey J, Mihalevich M, Mendelowitz D. 1998. Nicotine enhances presynaptic and postsynaptic glutamatergic neurotransmission to activate cardiac parasympathetic neurons. Circ Res 83:1241-1247.
44. Okumu FW, Lee RY, Blanchard JD, Queirolo A, Woods CM, Lloyd PM, Okikawa J, Gonda I, Farr SJ, Rubsamen R, Adjei AL, Bertz RJ. 2002. Evaluation of the AERx pulmonary delivery system for systemic delivery of a poorly soluble selective D-1 agonist, ABT-431. Pharm Res 19:1009-1012.
45. O'Neill MF, Dourish CT, Iversen SD. 1991. Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology (Berl) 104:343-350.
46. Parikh V, Man K, Decker MW, Sarter M. 2008. Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex. J Neurosci 28:3769-3780.
47. Placzek AN, Dani JA. 2009. Synaptic plasticity within midbrain dopamine centers contributes to nicotine addiction. Nebr Symp Motiv 55:5-15.
48. Placzek AN, Zhang TA, Dani JA. 2009. Nicotinic mechanisms influencing synaptic plasticity in the hippocampus. Acta Pharmacol Sin 30:752-760.
49. Reid MS, Fox L, Ho LB, Berger SP. 2000. Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: Neuropharmacological characterization. Synapse 35:129-136.
50. Rezvani K, Teng Y, Shim D, De Biasi M. 2007. Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity. J Neurosci 27:10508-10519.
51. Richardson SA, Tizabi Y. 1994. Hyperactivity in the offspring of nicotine-treated rats: Role of the mesolimbic and nigrostriatal dopaminergic pathways. Pharmacol Biochem Behav 47:331-337.
52. Rodvelt KR, Schachtman TR, Kracke GR, Miller DK. 2008. NMDA receptor blockade augmented nicotine-evoked dopamine release from rat prefrontal cortex slices. Neurosci Lett 440:319-322.
53. Steketee JD. 2003. Neurotransmitter systems of the medial prefrontal cortex: Potential role in sensitization to psychostimulants. Brain Res Rev 41:203-228.
54. Surmeier DJ, Bargas J, Hemmings HC, Nairn AC, Jr, Greengard P. 1995. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 14:385-397.
55. Threlfell S, Cragg SJ. 2011. Dopamine signaling in dorsal versus ventral striatum: The dynamic role of cholinergic interneurons. Front Syst Neurosci 5:1-10.
56. Trauth JA, Seidler FJ, McCook EC, Slotkin TA. 1999. Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res 851:9-19.
57. Toth E, Vizi ES, Lajtha A. 1993. Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo. Neuropharmacology 32:827-832.
58. Van den Oever MC, Spijker S, Smit AB. 2012. The synaptic pathology of drug addiction. Adv Exp Med Biol 970:469-491.
59. Vanderschuren LJ, Kalivas PW. 2000. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: A critical review of preclinical studies. Psychopharmacology (Berl) 151:99-120.
60. Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, Pennartz CM. 2004. Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 27:468-474.
61. Walsh RN, Cummins RA. 1976. The open-field test: A critical review. Psychol Bull 83:482-504.
62. Wang F, Chen H, Steketee JD, Sharp BM. 2007. Upregulation of ionotropic glutamate receptor subunits within specific mesocorticolimbic regions during chronic nicotine self-administration. Neuropsychopharmacology 32:103-109.
63. Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA. 2003. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci 23:3176-3185.
64. Yakel JL. 2013. Cholinergic receptors: Functional role of nicotinic Ach receptors in brain circuits and disease. Eur J Physiol 465:441-450.
65. Zahm DS. 1999. Functional-anatomical implications of the nucleus accumbens core and shell subterritories. Ann N Y Acad Sci 877:113-128.
66. Zahm DS. 2000. An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci Biobehav Rev 24:85-105.